{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:35:06Z","timestamp":1793316906504,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T00:00:00Z","timestamp":1714867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009473","name":"Universidad de M\u00e1laga","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hip fractures are the most serious fragility fractures due to their associated disability, higher hospitalization costs and high mortality rates. Fracture Liaison Service (FLS) programs have enhanced the management of osteoporosis-related fractures and have shown their clinical effectiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To analyze the effect of the implementation of a FLS model of care over the survival and mortality rates following a hip fracture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective cohort study on patients over 60\u00a0years of age who suffered a hip fracture before and after the implementation of the FLS in our center (between January 2016 and December 2019). Patients were followed for three years after the index date. Mortality, complications and refracture rates were compared between the two groups using a Multivariate Cox proportional hazard model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1366 patients were included in this study (353 before FLS implementation and 1013 after FLS implementation). Anti-osteoporotic drugs were more frequently prescribed after FLS implementation (79.3% vs 12.5%; p\u2009&lt;\u20090.01) and there was an increase in adherence to treatment (51.7% vs 30.2%; p\u2009&lt;\u20090.01). A total of 413 (40.8%) patients after FLS implementation and 141 (39.9%) individuals before (p\u2009=\u20090.47) died during the three-years follow-up period. A second fracture occurred in 101 (10.0%) patients after FLS implementation and 37 (10.5%) individuals before (p\u2009=\u20090.78). Patients after the implementation of the FLS protocol had a lower all cause one-year mortality [adjusted Hazard Ratio (HR) 0.74 (0.57\u20130.94)] and a decreased risk of suffering a second osteoporotic fracture [adjusted HR 0.54 (0.39\u20130.75)\u00a0in males and adjusted HR 0.46 (0.30\u20130.71) in females].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The implementation of a FLS protocol was associated with a lower all-cause one-year mortality rate and a higher survivorship in elderly hip fracture patients. However, no three-year mortality rate differences were observed between the two groups. We also found a reduction in the complication and second-fracture rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-024-02761-3","type":"journal-article","created":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T06:01:36Z","timestamp":1714888896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Secondary osteoporosis prevention: three-year outcomes from a Fracture Liaison Service in elderly hip fracture patients"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8881-4196","authenticated-orcid":false,"given":"David","family":"Gonz\u00e1lez-Quevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Rubia-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"S\u00e1nchez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Moriel-Garceso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"S\u00e1nchez-Siles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Bravo-Bardaj\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garc\u00eda-de-Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iskandar","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,5]]},"reference":[{"key":"2761_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","volume":"104","author":"CB Johnston","year":"2020","unstructured":"Johnston CB, Dagar M (2020) Osteoporosis in older adults. Med Clin North Am 104:873\u2013884. https:\/\/doi.org\/10.1016\/j.mcna.2020.06.004","journal-title":"Med Clin North Am"},{"key":"2761_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16:82. https:\/\/doi.org\/10.1007\/s11657-020-00871-9","journal-title":"Arch Osteoporos"},{"key":"2761_CR3","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jos.2019.02.019","volume":"24","author":"J-W Kim","year":"2019","unstructured":"Kim J-W, Kim D-H, Jang E-C et al (2019) Mortality and its risk factors in nonagenarians after hip fractures. J Orthop Sci 24:850\u2013854. https:\/\/doi.org\/10.1016\/j.jos.2019.02.019","journal-title":"J Orthop Sci"},{"key":"2761_CR4","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.injury.2018.04.015","volume":"49","author":"N Veronese","year":"2018","unstructured":"Veronese N, Maggi S (2018) Epidemiology and social costs of hip fracture. Injury 49:1458\u20131460. https:\/\/doi.org\/10.1016\/j.injury.2018.04.015","journal-title":"Injury"},{"key":"2761_CR5","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1007\/s40520-020-01497-0","volume":"32","author":"P Piscitelli","year":"2020","unstructured":"Piscitelli P, Neglia C, Feola M et al (2020) Updated incidence and costs of hip fractures in elderly Italian population. Aging Clin Exp Res 32:2587\u20132593. https:\/\/doi.org\/10.1007\/s40520-020-01497-0","journal-title":"Aging Clin Exp Res"},{"key":"2761_CR6","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K \u00c5kesson","year":"2013","unstructured":"IOF Fracture Working Group, \u00c5kesson K, Marsh D et al (2013) Capture the Fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135\u20132152. https:\/\/doi.org\/10.1007\/s00198-013-2348-z","journal-title":"Osteoporos Int"},{"key":"2761_CR7","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00198-021-05911-9","volume":"32","author":"N Li","year":"2021","unstructured":"Li N, Hiligsmann M, Boonen A et al (2021) The impact of fracture liaison services on subsequent fractures and mortality: a systematic literature review and meta-analysis. Osteoporos Int 32:1517\u20131530. https:\/\/doi.org\/10.1007\/s00198-021-05911-9","journal-title":"Osteoporos Int"},{"key":"2761_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00198-019-05153-w","volume":"31","author":"D Gonz\u00e1lez-Quevedo","year":"2020","unstructured":"Gonz\u00e1lez-Quevedo D, Bautista-Enrique D, P\u00e9rez-del-R\u00edo V et al (2020) Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study. Osteoporos Int 31:77\u201384. https:\/\/doi.org\/10.1007\/s00198-019-05153-w","journal-title":"Osteoporos Int"},{"key":"2761_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00198-022-06298-x","volume":"33","author":"D Gonz\u00e1lez-Quevedo","year":"2022","unstructured":"Gonz\u00e1lez-Quevedo D, P\u00e9rez-del-R\u00edo V, Moriel-Garceso D et al (2022) A 2-year follow-up of a novel fracture liaison service: can we reduce the mortality in elderly hip fracture patients? a prospective cohort study. Osteoporos Int 33:1695\u20131702. https:\/\/doi.org\/10.1007\/s00198-022-06298-x","journal-title":"Osteoporos Int"},{"key":"2761_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3\u201344. https:\/\/doi.org\/10.1007\/s00198-018-4704-5. (on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF))","journal-title":"Osteoporos Int"},{"key":"2761_CR11","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"key":"2761_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.reumae.2018.09.011","volume":"15","author":"A Naranjo Hern\u00e1ndez","year":"2019","unstructured":"Naranjo Hern\u00e1ndez A, Del Campo D, Fontecha P et al (2019) Recommendations by the spanish society of rheumatology on osteoporosis. Reumatolog\u00eda Cl\u00ednica (English Edition) 15:188\u2013210. https:\/\/doi.org\/10.1016\/j.reumae.2018.09.011","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"2761_CR13","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/jbmr.4674","volume":"37","author":"L Vranken","year":"2022","unstructured":"Vranken L, De Bruin IJA, Driessen AHM et al (2022) Decreased mortality and subsequent fracture risk in patients with a major and hip fracture after the introduction of a fracture liaison service: a 3-Year follow-up survey. JBMR 37:2025\u20132032. https:\/\/doi.org\/10.1002\/jbmr.4674","journal-title":"JBMR"},{"key":"2761_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116216","volume":"154","author":"T-W Tai","year":"2022","unstructured":"Tai T-W, Li C-C, Huang C-F et al (2022) Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study. Bone 154:116216. https:\/\/doi.org\/10.1016\/j.bone.2021.116216","journal-title":"Bone"},{"key":"2761_CR15","doi-asserted-by":"publisher","first-page":"215145932097997","DOI":"10.1177\/2151459320979978","volume":"12","author":"DW Barton","year":"2021","unstructured":"Barton DW, Piple AS, Smith CT et al (2021) The clinical impact of fracture liaison services: a systematic review. Geriatr Orthop Surg Rehabil 12:215145932097997. https:\/\/doi.org\/10.1177\/2151459320979978","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"2761_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/os.12517","volume":"11","author":"P Wang","year":"2019","unstructured":"Wang P, Li Y, Zhuang H et al (2019) Anti-osteoporosis medications associated with decreased mortality after hip fracture. Orthop Surg 11:777\u2013783. https:\/\/doi.org\/10.1111\/os.12517","journal-title":"Orthop Surg"},{"key":"2761_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jbmr.3860","volume":"35","author":"IR Reid","year":"2020","unstructured":"Reid IR, Horne AM, Mihov B et al (2020) Effects of zoledronate on cancer, cardiac events, and mortality in osteopenic older women. J Bone Miner Res 35:20\u201327. https:\/\/doi.org\/10.1002\/jbmr.3860","journal-title":"J Bone Miner Res"},{"key":"2761_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/os.12460","volume":"11","author":"Z Liu","year":"2019","unstructured":"Liu Z, Li C, Mao Y et al (2019) Study on zoledronic acid reducing acute bone loss and fracture rates in elderly postoperative patients with intertrochanteric fractures. Orthop Surg 11:380\u2013385. https:\/\/doi.org\/10.1111\/os.12460","journal-title":"Orthop Surg"},{"key":"2761_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12020-018-1824-9","volume":"64","author":"L Degli Esposti","year":"2019","unstructured":"Degli Esposti L, Girardi A et al (2019) Use of antiosteoporotic drugs and calcium\/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk. Endocrine 64:367\u2013377. https:\/\/doi.org\/10.1007\/s12020-018-1824-9","journal-title":"Endocrine"},{"key":"2761_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11657-019-0657-3","volume":"14","author":"A Cobden","year":"2019","unstructured":"Cobden A, Cobden SB, Camurcu Y et al (2019) Effects of postoperative osteoporosis treatment on subsequent fracture and the 5-year survival rates after hemiarthroplasty for hip fracture. Arch Osteoporos 14:100. https:\/\/doi.org\/10.1007\/s11657-019-0657-3","journal-title":"Arch Osteoporos"},{"key":"2761_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0162097","volume":"11","author":"O Kilci","year":"2016","unstructured":"Kilci O, Un C, Sacan O et al (2016) Postoperative mortality after hip fracture surgery: a 3 years follow up. PLoS ONE 11:e0162097. https:\/\/doi.org\/10.1371\/journal.pone.0162097","journal-title":"PLoS ONE"},{"key":"2761_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-022-04719-4","author":"FA Miralles-Mu\u00f1oz","year":"2022","unstructured":"Miralles-Mu\u00f1oz FA, Perez-Aznar A, Gonzalez-Parre\u00f1o S et al (2022) Change in 1-year mortality after hip fracture surgery over the last decade in a European population. Arch Orthop Trauma Surg. https:\/\/doi.org\/10.1007\/s00402-022-04719-4","journal-title":"Arch Orthop Trauma Surg"},{"key":"2761_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s40520-018-1047-1","volume":"31","author":"C Trevisan","year":"2019","unstructured":"Trevisan C, Gallinari G, Klumpp R et al (2019) Year to year comparison of 2000\u20132015 in hip fracture management: same survival rate despite older and more fragile patients. Aging Clin Exp Res 31:1097\u20131103. https:\/\/doi.org\/10.1007\/s40520-018-1047-1","journal-title":"Aging Clin Exp Res"},{"key":"2761_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11657-022-01148-z","volume":"17","author":"R Tiihonen","year":"2022","unstructured":"Tiihonen R, Helkamaa T, Nurmi-L\u00fcthje I et al (2022) Patient-specific factors affecting survival following hip fractures\u2014a 14-year follow-up study in Finland. Arch Osteoporos 17:107. https:\/\/doi.org\/10.1007\/s11657-022-01148-z","journal-title":"Arch Osteoporos"},{"key":"2761_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027049","volume":"9","author":"F Fatoye","year":"2019","unstructured":"Fatoye F, Smith P, Gebrye T et al (2019) Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review. BMJ Open 9:e027049. https:\/\/doi.org\/10.1136\/bmjopen-2018-027049","journal-title":"BMJ Open"},{"key":"2761_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00774-022-01358-y","volume":"40","author":"M Chen","year":"2022","unstructured":"Chen M, Du Y, Tang W et al (2022) Risk factors of mortality and second fracture after elderly hip fracture surgery in Shanghai, China. J Bone Miner Metab 40:951\u2013959. https:\/\/doi.org\/10.1007\/s00774-022-01358-y","journal-title":"J Bone Miner Metab"},{"key":"2761_CR27","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.injury.2017.06.014","volume":"48","author":"D Gonz\u00e1lez Quevedo","year":"2017","unstructured":"Gonz\u00e1lez Quevedo D, Mari\u00f1o IT, S\u00e1nchez Siles JM et al (2017) Patient survival and surgical re-intervention predictors for intracapsular hip fractures. Injury 48:1831\u20131836. https:\/\/doi.org\/10.1016\/j.injury.2017.06.014","journal-title":"Injury"},{"key":"2761_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12603-022-1762-3","volume":"26","author":"V Dauny","year":"2022","unstructured":"Dauny V, Thietart S, Cohen-Bittan J et al (2022) Association between vitamin d deficiency and prognosis after hip fracture surgery in older patients in a dedicated orthogeriatric care pathway. J Nutr Health Aging 26:324\u2013331. https:\/\/doi.org\/10.1007\/s12603-022-1762-3","journal-title":"J Nutr Health Aging"},{"key":"2761_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281313","volume":"18","author":"N Fu","year":"2023","unstructured":"Fu N, Miao M, Li N et al (2023) Association between vitamin D concentration and delirium in hospitalized patients: a meta-analysis. PLoS ONE 18:e0281313. https:\/\/doi.org\/10.1371\/journal.pone.0281313","journal-title":"PLoS ONE"},{"key":"2761_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00198-015-3443-0","volume":"27","author":"A Nakayama","year":"2016","unstructured":"Nakayama A, Major G, Holliday E et al (2016) Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int 27:873\u2013879. https:\/\/doi.org\/10.1007\/s00198-015-3443-0","journal-title":"Osteoporos Int"},{"key":"2761_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.amjsurg.2018.09.027","volume":"217","author":"T Wasfie","year":"2019","unstructured":"Wasfie T, Jackson A, Brock C et al (2019) Does a fracture liaison service program minimize recurrent fragility fractures in the elderly with osteoporotic vertebral compression fractures? Am J Surg 217:557\u2013560. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.09.027","journal-title":"Am J Surg"},{"key":"2761_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10211","volume":"3","author":"P Geusens","year":"2019","unstructured":"Geusens P, Oates M, Miyauchi A et al (2019) The effect of 1 year of romosozumab on the incidence of clinical vertebral fractures in postmenopausal women with osteoporosis: results from the frame study: clinical vertebral fractures after romosozumab or placebo. JBMR Plus 3:e10211. https:\/\/doi.org\/10.1002\/jbm4.10211","journal-title":"JBMR Plus"},{"key":"2761_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1759720X17706464","volume":"9","author":"IJA de Bruin","year":"2017","unstructured":"de Bruin IJA, Wyers CE, van den Bergh JPW et al (2017) Fracture liaison services: do they reduce fracture rates? Therapeutic Advances in Musculoskeletal Disease 9:157\u2013164. https:\/\/doi.org\/10.1177\/1759720X17706464","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"key":"2761_CR34","doi-asserted-by":"publisher","first-page":"e068033","DOI":"10.1136\/bmj-2021-068033","volume":"2","author":"MN H\u00e4ndel","year":"2023","unstructured":"H\u00e4ndel MN, Cardoso I, Von B\u00fclow C et al (2023) Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ 2:e068033. https:\/\/doi.org\/10.1136\/bmj-2021-068033","journal-title":"BMJ"},{"key":"2761_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115558","volume":"140","author":"I Tamimi","year":"2020","unstructured":"Tamimi I, Cortes ARG, S\u00e1nchez-Siles J-M et al (2020) Composition and characteristics of trabecular bone in osteoporosis and osteoarthritis. Bone 140:115558. https:\/\/doi.org\/10.1016\/j.bone.2020.115558","journal-title":"Bone"},{"key":"2761_CR36","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.injury.2020.02.014","volume":"51","author":"JM Sanchez-Siles","year":"2020","unstructured":"Sanchez-Siles JM, Tamimi-Mari\u00f1o I, Cortes ARG et al (2020) Age related changes in the bone microstructure in patients with femoral neck fractures. Injury 51:S12\u2013S18. https:\/\/doi.org\/10.1016\/j.injury.2020.02.014","journal-title":"Injury"},{"key":"2761_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jbmr.3877","volume":"35","author":"RB Conley","year":"2020","unstructured":"Conley RB, Adib G, Adler RA et al (2020) Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition. J Bone Miner Res 35:36\u201352. https:\/\/doi.org\/10.1002\/jbmr.3877","journal-title":"J Bone Miner Res"},{"key":"2761_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","volume":"15","author":"F Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m F, Karlsson L et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15:59. https:\/\/doi.org\/10.1007\/s11657-020-0706-y. (for the International Osteoporosis Foundation,)","journal-title":"Arch Osteoporos"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-024-02761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-024-02761-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-024-02761-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T22:09:06Z","timestamp":1734732546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-024-02761-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2761"],"URL":"https:\/\/doi.org\/10.1007\/s40520-024-02761-3","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,5]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial or not-profit sectors. David Gonz\u00e1lez-Quevedo, Juan-Manuel S\u00e1nchez-Siles, Manuel Bravo-Bardaj\u00ed and David Garc\u00eda-de-Quevedo have received in the last 5 years honoraria for lecture fees or financial support for attending symposia from Stada, Gedeon-Richter, Theramex, Gr\u00fcnenthal and Amgen. Carolina Rubia-Ortega, Adriana S\u00e1nchez-Delgado, Diego Moriel-Garceso and Iskandar Tamimi report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"103"}}